Natural Product: NPC483459

Natural Product IDNPC483459
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
IYWKCXXBLCNUEK-MIDUXASESA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001549] Monoterpenoids
          • [CHEMONTID:0001564] Bicyclic monoterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey IYWKCXXBLCNUEK-MIDUXASESA-N
Standard InCHI InChI=1S/C22H30O4/c1-15(6-5-7-16(2)14-23)10-20(25)13-22(4)9-8-18-12-19(24)11-17(3)21(18)26-22/h7,10-12,23-24H,5-6,8-9,13-14H2,1-4H3/b15-10-,16-7-/t22-/m0/s1
SMILES C/C(=C/C(=O)C[C@]1(C)CCc2cc(cc(C)c2O1)O)/CC/C=C(/C)CO

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   358.21 Volume:   391.297
?
Van der Waals volume.
Dense:   0.915 LogP:   4.222
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.546
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.604
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   14.0
TPSA:   66.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   2.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.56 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.696 Fsp3:   0.5
MCE-18:   50.909
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.441 Fluc inhibitor:   0.002
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.058
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.422
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.391 Promiscuous compounds:   0.007

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.102 MDCK Permeability:   -4.848
Pgp-inhibitor:   0.023 Pgp-substrate:   0.126
PAMPA:   0.491
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.551 30% Bioavailability (F30%):   0.225
50% Bioavailability (F50%):   0.964

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.933 MRP1:   0.997
Plasma Protein Binding (PPB):   91.473% Volume Distribution (VD):   0.137
Fu: 9.589%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.822
OATP1B3 inhibitor:   0.698 BCRP inhibitor:   0.034
BSEP inhibitor:   0.977

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.071
CYP2C19-inhibitor:   0.571 CYP2C19-substrate:   0.006
CYP2C9-inhibitor:   0.043 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.048 CYP2D6-substrate:   0.074
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.997
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.836
HLM stability:   0.391
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.174 Half-life (T1/2):  0.817

ADMET: Toxicity

hERG Blockers:  0.109 hERG Blockers (10um):  0.354
Human Hepatotoxicity (H-HT):  0.631 Drug-induced Liver Injury (DILI):  0.008
AMES Toxicity:  0.141 Rat Oral Acute Toxicity:  0.031
Maximum Recommended Daily Dose:  0.386 Skin Sensitization:  0.985
Carcinogencity:  0.333 Eye Corrosion:  0.029
Eye Irritation:  0.971 Respiratory Toxicity:  0.556
Drug-induced Neurotoxicity:  0.32 Ototoxicity:  0.321
Hematotoxicity:  0.124 Drug-induced Nephrotoxicity:  0.289
Genotoxicity:  0.008 RPMI-8226 Immunitoxicity:  0.044
A549 Cytotoxicity:  0.032 Hek293 Cytotoxicity:  0.221
BCF:   2.004
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.722
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.172
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.492
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40176 Koeberlinia spinosa Species Koeberliniaceae Eukaryota n.a. n.a. n.a. PMID[29048892]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell line A2780 Homo sapiens IC50 > 10000.0 nM PMID[29048892]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 112000.0 nM PMID[29048892]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC483459 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC483457
1.0 High Similarity NPC483456
1.0 High Similarity NPC483458
0.7581 Intermediate Similarity NPC32152
0.75 Intermediate Similarity NPC483460
0.6567 Remote Similarity NPC483462
0.6471 Remote Similarity NPC610467
0.6406 Remote Similarity NPC69539
0.6338 Remote Similarity NPC59654
0.6286 Remote Similarity NPC611336
0.6269 Remote Similarity NPC147896
0.6197 Remote Similarity NPC609807
0.6111 Remote Similarity NPC271832
0.6111 Remote Similarity NPC600119
0.6111 Remote Similarity NPC601388
0.5972 Remote Similarity NPC474131
0.5833 Remote Similarity NPC232295
0.5797 Remote Similarity NPC606596
0.5753 Remote Similarity NPC204535
0.5753 Remote Similarity NPC46586
0.5753 Remote Similarity NPC185634
0.5733 Remote Similarity NPC610755
0.5616 Remote Similarity NPC483461
0.5526 Remote Similarity NPC603704
0.5455 Remote Similarity NPC474246
0.5455 Remote Similarity NPC474130
0.5405 Remote Similarity NPC276962
0.5405 Remote Similarity NPC190086
0.5395 Remote Similarity NPC196621
0.5385 Remote Similarity NPC474143
0.5385 Remote Similarity NPC609153
0.5325 Remote Similarity NPC474237
0.5256 Remote Similarity NPC475880

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC483459 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data